Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis

Neuroscience

Volumn 169, Issue 2, 2010, Pages 812-827

  Malaspina, A ^a   Ngoh, S F A ^a   Ward, R E ^a   Hall, J C E ^a   Tai, F W D ^a   Yip, P K ^a   Jones, C ^a   Jokic, N ^a   Averill, S A ^a   Michael Titus, A T ^a   Priestley, J V ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ALS; ATF 3; Bead array analysis; Dorsal root ganglia; Spinal cord

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; BIOLOGICAL MARKER; PARVALBUMIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELL ORGANELLE; CELL SIZE; CELL STRESS; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LUMBAR SPINAL CORD; MACROPHAGE; MALE; MOTONEURON; NERVE CELL; NEUROFILAMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RAT; SCHWANN CELL; SENSORY STIMULATION; SPINAL CORD ATROPHY; SPINAL GANGLION; TRANSCRIPTION REGULATION; VENTRAL ROOT;

ACTIVATING TRANSCRIPTION FACTOR 3; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; GENE EXPRESSION PROFILING; MALE; NERVE DEGENERATION; NEUROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SPINAL CORD; SPINAL NERVE ROOTS; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 77954620620     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.04.053     Document Type: Article

References (47)

1. Averill A., Gregory J., Shortland P.J., Leavesley R.C., King V., Bradbury E.J., Mcmahon S.B., Priestley J.V. NGF and GDNF ameliorate the increase in ATF3 expression which occurs in dorsal root ganglion cells in response to peripheral nerve injury. Eur J Neurosci 2004, 19:1437-1445.
2. Beyrouthy M.J., Alexander K.E., Baldwin A., Whitfield M.L., Bass H.W., McGee D., Hurt M.M. Identification of G1-regulated genes in normally cycling human cells. PLoS One 2008, 3:e3943.
3. Bloechlinger S., Karchewski L.A., Woolf C.J. Dynamic changes in glypican-1 expression in dorsal root ganglion neurons after peripheral and central axonal injury. Eur J Neurosci 2004, 19:1119-1132.
4. Boillée S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
5. Campbell G., Hutchins K., Winterbottom J., Grenningloh G., Lieberman A.R., Anderson P.N. Upregulation of activating transcription factor 3 (ATF3) by intrinsic CNS neurons regenerating axons into peripheral nerve grafts. Exp Neurol 2005, 192:340-347.
6. Chen H.H., Wang D.L. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. Mol Pharmacol 2004, 65:1130-1140.
7. Chen X.J., Levedakou E.N., Millen K.J., Wollmann R.L., Soliven J., Popko B. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic dynein heavy chain 1 gene. J Neurosci 2007, 27:14515-14524.
8. Dupuis L., Fergani A., Braunstein K.E., et al. Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp Neurol 2009, 215:146-152.
9. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Kennedy K., Hai T., Bolouri H., Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
10. Gonzalez de Aguilar J.L., Niederhauser-Wiederkehr C., Halter B., De Tapia M., Di Scala F., Demougin P., Dupuis L., Primig M., Meininger V., Loeffler J.P. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 2008, 32:207-218.
11. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 2006, 26:8774-8786.
12. Heads T., Pollock M., Robertson A., Sutherland W.H., Allpress S. Sensory nerve pathology in amyotrophic lateral sclerosis. Acta Neuropathol 1991, 82:316-320.
13. Ho H.H., Antoniv T.T., Ji J.D., Ivashkiv L.B. Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1. J Immunol 2008, 181:5089-5097.
14. Hossain-Ibrahim M.K., Rezajooi K., MacNally J.K., Mason M.R., Lieberman A.R., Anderson P.N. Effects of lipopolysaccharide-induced inflammation on expression of growth-associated genes by corticospinal neurons. BMC Neurosci 2006, 7:8.
15. Hsin-Mei C., Lulu W., Santosh D'Mello R. Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074. J Neurochem 2007, 105:1300-1312.
16. Huang W.L., George K.J., Ibba V., Liu M.C., Averill S., Quartu M., Hamlyn P.J., Priestley J.V. The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur J Neurosci 2007, 25:362-372.
17. Huang W.L., Robson D., Liu M.C., Averill S., Shortland P.J., Priestley J.V. Spinal cord compression and dorsal root injury causes up-regulation of activating transcription factor-3 in large diameter dorsal root ganglion neurons. Eur J Neurosci 2006, 23:273-278.
18. Hunt D., Hossain-Ibrahim K., Mason M.R., Coffin R.S., Lieberman A.R., Winterbottom J., Anderson P.N. ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matter. BMC Neurosci 2004, 4:5-9.
19. Isaacs J.D., Dean A.F., Shaw C.E., Al-Chalabi A., Mills K.R., Leigh P.N. Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?. J Neurol Neurosurg Psychiatry 2007, 78:750-753.
20. Jiang H.J., Jiang L., Wek R.C. The eukaryotic initiation factor 2 kinase pathway facilitates differential GADD45a expression in response to environmental stress. J Biol 2007, 282:3755-3765.
21. Jiang H.Y., Wek S.A., McGrath B.C., Lu D., Hai T., Harding H.P., Wang X., Ron D., Cavener D.R., Wek R.C. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 2004, 24:1365-1377.
22. Jokic N., Ling Y.Y., Ward R.R., Michael-Titus A.T., Priestley J.V., Malaspina A. Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J Neurochem 2007, 103:1821-1833.
23. Kawamura Y., Dyck P.J., Shimono M., Okazaki H., Tateishi J., Doi H. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1981, 40:667-675.
24. Keller A.F., Gravel M., Kriz J. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia 2009, 57:1130-1142.
25. Khuu C.H., Barrozo R.M., Hai T., Weinstein S.L. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. Mol Immunol 2007, 44:1598-1605.
26. Kiryu-Seo S., Kato R., Ogawa T., Nakagomi S., Nagata K., Kiyama H. Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. J Biol Chem 2008, 83:6988-6996.
27. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein K., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999, 5:347-350.
28. Lehotský J., Urban P., Pavlíková M., Tatarková Z., Kaminska B., Kaplán P. Molecular mechanisms leading to neuroprotection/ischemic tolerance: effect of preconditioning on the stress reaction of endoplasmic reticulum. Cell Mol Neurobiol 2009, 29:917-925.
29. Liu R., Chen X.P., Tao L.Y. Regulation of axonal regeneration following the central nervous system injury in adult mammalian. Neurosci Bull 2008, 24:395-400.
30. Lukas T.J., Luo W.W., Mao H., Cole N., Siddique T. Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis. Mol Cell Proteomics 2006, 5:1233-1244.
31. Malaspina A., de Belleroche J. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res Rev 2004, 45:213-229.
32. Malaspina A., Jokic N., Huang W.L., Priestley J.V. Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression. BMC Genomics 2008, 9:500.
33. Nagai M., Aoki M., Miyoshi I., Kato M., Pasinelli P., Kasai N., Brown R.H., Itoyama Y. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 2001, 21:9246-9254.
34. Ohba N., Kiryu-Seo S., Maeda M., Muraoka M., Ishii M., Kiyama H. Expression of damage-induced neuronal endopeptidase (DINE) mRNA in peri-infarct cortical and thalamic neurons following middle cerebral artery occlusion. J Neurochem 2004, 91:956-964.
35. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
36. Seijffers R., Mills C.D., Woolf C.J. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J Neurosci 2007, 27:7911-7920.
37. Seilhean D., Cazeneuve C., Thuriès V., Russaouen O., Millecamps S., Salachas F., Meininger V., Leguern E., Duyckaerts C. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol 2009, 118:561-573.
38. Slentz-Kesler K.A., Hale L.P., Kaufman R.E. Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms. Genomics 1998, 47:327-340.
39. Song D., Young Y.Y., Shin D.H., Shue S., Kim Y.S., Lee B.H., Tong H., Cho B.P. Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression. Exp Neurol 2008, 209:268-278.
40. Theys P.A., Peeters E., Robberecht W. Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J Neurol 1999, 246:438-442.
41. Tsujino H., Kondo E., Fukuoka T., Dai Y., Tokunaga A., Miki K., Yonenobu K., Ochi T., Noguchi K. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Mol Cell Neurosci 2000, 15:170-182.
42. Ullian E.M., Harris B.T., Wu A., Chan J.R., Barres B.A. Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture. Mol Cell Neurosci 2003, 25:241-251.
43. Vlug A.S., Teuling E., Haasdijk E.D., French P., Hoogenraad C.C., Jaarsma D. ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur J Neurosci 2005, 22:1881-1894.
44. Whitmore M.M., Iparraguirre A., Kubelka L., Weninger W., Hai T., Williams B.R. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol 2007, 179:3622-3630.
45. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008, 11:251-253.
46. Yamanaka K., Boillee S., Roberts E.A., Garcia M.L., McAlonis-Downes M., Mikse O.R., Cleveland D.W., Goldstein L.S. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A 2008, 105:7594-7599.
47. Zeeber B.R., Qin H., Narasimhan S., et al. High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 2005, 6:168.